Harrow, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Harrow, Inc. 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About HROW

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. 

CEO
Mark L. Baum
CEOMark L. Baum
Employees
373
Employees373
Headquarters
Nashville, Tennessee
HeadquartersNashville, Tennessee
Founded
2006
Founded2006
Employees
373
Employees373

HROW Key Statistics

Market cap
1.19B
Market cap1.19B
Price-Earnings ratio
-75.53
Price-Earnings ratio-75.53
Dividend yield
Dividend yield
Average volume
1.38M
Average volume1.38M
High today
$32.27
High today$32.27
Low today
$30.03
Low today$30.03
Open price
$30.64
Open price$30.64
Volume
938.48K
Volume938.48K
52 Week high
$54.85
52 Week high$54.85
52 Week low
$25.21
52 Week low$25.21

Stock Snapshot

As of today, Harrow, Inc.(HROW) shares are valued at $31.99. The company's market cap stands at 1.19B, with a P/E ratio of -75.53.

As of 2026-05-21, Harrow, Inc.(HROW) stock has fluctuated between $30.03 and $32.27. The current price stands at $31.99, placing the stock +6.5% above today's low and -0.9% off the high.

Harrow, Inc.(HROW) shares are trading with a volume of 938.48K, against a daily average of 1.38M.

During the past year, Harrow, Inc.(HROW) stock moved between $25.21 at its lowest and $54.85 at its peak.

During the past year, Harrow, Inc.(HROW) stock moved between $25.21 at its lowest and $54.85 at its peak.

HROW News

TipRanks 2d
Two Harrow Health Insiders Just Made Bold Moves on the Stock

New insider activity at Harrow Health ( (HROW) ) has taken place on May 19, 2026. Unlock hedge fund-level data and powerful investing tools for smarter, sharpe...

Investing.com 3d
Earnings call transcript: Harrow Health Q1 2026 results miss expectations - Investing.com

...

Earnings call transcript: Harrow Health Q1 2026 results miss expectations - Investing.com

Analyst ratings

100%

of 8 ratings
Buy
100%
Hold
0%
Sell
0%

People also own

Based on the portfolios of people who own HROW. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.